Add like
Add dislike
Add to saved papers

THE NATURE AND FEATURES OF SURROGACY AS AN ASSISTED REPRODUCTIVE TECHNOLOGY.

The purpose of the article is to analyze certain aspects of modern discourse concerning the nature of surrogacy and its features, including the outline of the main legal obligations arising from the surrogacy technology application. The methodological basis of this work is a system of methods, scientific approaches, techniques, and principles that were aimed at achieving the study objectives. Universal, general scientific and special legal methods were used. Thus, for example, the methods of analysis, synthesis, induction, and deduction allowed to generalize the acquired knowledge, which became the basis of scientific intelligence, while the comparative method allowed to explain the specifics of normative regulation of the studied issues in separate countries. On the basis of the research, various scientific approaches to the concept of surrogacy, its types and the main legislative regimes for its application were analyzed, based on the experience of foreign countries. Since the state is responsible for creating and ensuring effective mechanisms for the realization of reproductive rights of citizens, the authors emphasize the need for clear legislative definition and regulation of legal obligations in the application of surrogacy technology, including responsibilities mentioned in the research, namely: the obligation of the surrogate mother to transfer the child to the expected parents after birth and the obligation of future parents to officially recognize the born child and accept parental responsibility for it. This would make it possible to protect the rights and interests, in particular, of children born through the use of surrogacy technology, as well as the reproductive rights of the child's future parents and the rights of the surrogate mother.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app